These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
313 related articles for article (PubMed ID: 19795179)
1. Rarely occurring mutation of ACVR1 gene in Moroccan patient with fibrodysplasia ossificans progressiva. Ratbi I; Bocciardi R; Regragui A; Ravazzolo R; Sefiani A Clin Rheumatol; 2010 Jan; 29(1):119-21. PubMed ID: 19795179 [TBL] [Abstract][Full Text] [Related]
2. BMP signaling and skeletal development in fibrodysplasia ossificans progressiva (FOP). Towler OW; Shore EM Dev Dyn; 2022 Jan; 251(1):164-177. PubMed ID: 34133058 [TBL] [Abstract][Full Text] [Related]
3. The ACVR1 R206H mutation found in fibrodysplasia ossificans progressiva increases human induced pluripotent stem cell-derived endothelial cell formation and collagen production through BMP-mediated SMAD1/5/8 signaling. Barruet E; Morales BM; Lwin W; White MP; Theodoris CV; Kim H; Urrutia A; Wong SA; Srivastava D; Hsiao EC Stem Cell Res Ther; 2016 Aug; 7(1):115. PubMed ID: 27530160 [TBL] [Abstract][Full Text] [Related]
4. Fibrodysplasia ossificans progressiva: middle-age onset of heterotopic ossification from a unique missense mutation (c.974G>C, p.G325A) in ACVR1. Whyte MP; Wenkert D; Demertzis JL; DiCarlo EF; Westenberg E; Mumm S J Bone Miner Res; 2012 Mar; 27(3):729-37. PubMed ID: 22131272 [TBL] [Abstract][Full Text] [Related]
5. ACVR1 (587T>C) mutation in a variant form of fibrodysplasia ossificans progressiva: second report. Nakahara Y; Katagiri T; Ogata N; Haga N Am J Med Genet A; 2014 Jan; 164A(1):220-4. PubMed ID: 24259422 [TBL] [Abstract][Full Text] [Related]
6. A case of Fibrodysplasia Ossificans Progressiva associated with a novel variant of the ACVR1 gene. Cappato S; Traberg R; Gintautiene J; Zara F; Bocciardi R Mol Genet Genomic Med; 2021 Oct; 9(10):e1774. PubMed ID: 34347384 [TBL] [Abstract][Full Text] [Related]
7. Skeletal malformations and developmental arthropathy in individuals who have fibrodysplasia ossificans progressiva. Towler OW; Shore EM; Kaplan FS Bone; 2020 Jan; 130():115116. PubMed ID: 31655222 [TBL] [Abstract][Full Text] [Related]
8. Classic and atypical fibrodysplasia ossificans progressiva (FOP) phenotypes are caused by mutations in the bone morphogenetic protein (BMP) type I receptor ACVR1. Kaplan FS; Xu M; Seemann P; Connor JM; Glaser DL; Carroll L; Delai P; Fastnacht-Urban E; Forman SJ; Gillessen-Kaesbach G; Hoover-Fong J; Köster B; Pauli RM; Reardon W; Zaidi SA; Zasloff M; Morhart R; Mundlos S; Groppe J; Shore EM Hum Mutat; 2009 Mar; 30(3):379-90. PubMed ID: 19085907 [TBL] [Abstract][Full Text] [Related]
9. Overexpression of Wild-Type ACVR1 in Fibrodysplasia Ossificans Progressiva Mice Rescues Perinatal Lethality and Inhibits Heterotopic Ossification. Yamamoto M; Stoessel SJ; Yamamoto S; Goldhamer DJ J Bone Miner Res; 2022 Nov; 37(11):2077-2093. PubMed ID: 35637634 [TBL] [Abstract][Full Text] [Related]
11. Fibrodysplasia ossificans progressiva (FOP): A disorder of osteochondrogenesis. Kaplan FS; Al Mukaddam M; Stanley A; Towler OW; Shore EM Bone; 2020 Nov; 140():115539. PubMed ID: 32730934 [TBL] [Abstract][Full Text] [Related]
12. Fibrodysplasia ossificans progressiva (FOP): watch the great toes! Kartal-Kaess M; Shore EM; Xu M; Schwering L; Uhl M; Korinthenberg R; Niemeyer C; Kaplan FS; Lauten M Eur J Pediatr; 2010 Nov; 169(11):1417-21. PubMed ID: 20577760 [TBL] [Abstract][Full Text] [Related]
13. The serum levels of activin A and bone morphogenetic protein-4 and -6 in patients with fibrodysplasia ossificans progressiva. Ye Z; Wang S; Shan C; Zhu Q; Xue Y; Zhang K Orphanet J Rare Dis; 2023 May; 18(1):111. PubMed ID: 37165433 [TBL] [Abstract][Full Text] [Related]
14. Mutational analysis of the ACVR1 gene in Italian patients affected with fibrodysplasia ossificans progressiva: confirmations and advancements. Bocciardi R; Bordo D; Di Duca M; Di Rocco M; Ravazzolo R Eur J Hum Genet; 2009 Mar; 17(3):311-8. PubMed ID: 18830232 [TBL] [Abstract][Full Text] [Related]
15. The obligatory role of Activin A in the formation of heterotopic bone in Fibrodysplasia Ossificans Progressiva. Alessi Wolken DM; Idone V; Hatsell SJ; Yu PB; Economides AN Bone; 2018 Apr; 109():210-217. PubMed ID: 28629737 [TBL] [Abstract][Full Text] [Related]
16. Palovarotene Inhibits Heterotopic Ossification and Maintains Limb Mobility and Growth in Mice With the Human ACVR1(R206H) Fibrodysplasia Ossificans Progressiva (FOP) Mutation. Chakkalakal SA; Uchibe K; Convente MR; Zhang D; Economides AN; Kaplan FS; Pacifici M; Iwamoto M; Shore EM J Bone Miner Res; 2016 Sep; 31(9):1666-75. PubMed ID: 26896819 [TBL] [Abstract][Full Text] [Related]
17. Allele-Selective LNA Gapmers for the Treatment of Fibrodysplasia Ossificans Progressiva Knock Down the Pathogenic ACVR1 Maruyama R; Nguyen Q; Roshmi RR; Touznik A; Yokota T Nucleic Acid Ther; 2022 Jun; 32(3):185-193. PubMed ID: 35085461 [TBL] [Abstract][Full Text] [Related]
18. Role of altered signal transduction in heterotopic ossification and fibrodysplasia ossificans progressiva. Shore EM; Kaplan FS Curr Osteoporos Rep; 2011 Jun; 9(2):83-8. PubMed ID: 21340697 [TBL] [Abstract][Full Text] [Related]
19. Nonclassic fibrodysplasia ossificans progressiva: A child from Angola with an ACVR1 Martín-García D; Towler OW; Xu M; Alfonso-Hernández O; Oliveira PR; Alonso-Clavo M; Shore EM; Kaplan FS Am J Med Genet A; 2021 Aug; 185(8):2572-2575. PubMed ID: 33973349 [TBL] [Abstract][Full Text] [Related]
20. Hints on transcriptional control of essential players in heterotopic ossification of Fibrodysplasia Ossificans Progressiva. Ravazzolo R; Cappato S; Bocciardi R Bone; 2018 Apr; 109():187-191. PubMed ID: 29100956 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]